Peripheral blood CD19+ B cell levels in patients with COVID-19 during the acute stage of the disease were lower compared to control values; however, there was an increase in the proportion of circulating CD27hiCD38hiCD24− plasma cell precursors [11]. This evidence concerns the gene CD19 and COVID-19.